
2022-05-21 13:38:14
Dupixent® Receives FDA Approval to Treat EoE in People Ages 12 and Older
Dupixent® Receives FDA Approval to Treat EoE in People Ages 12 and Older Injection is the first indicated treatment for EoE ...
Find out More2022-05-25 17:37:36
2022-05-21 13:38:14
Dupixent® Receives FDA Approval to Treat EoE in People Ages 12 and Older Injection is the first indicated treatment for EoE ...
Find out More2022-05-13 13:08:56
Atlanta, GA (May 13, 2022) – The American Partnership for Eosinophilic Disorders (APFED) will celebrate the ...
Find out More2022-05-04 09:46:52
Mark your calendars for National Eosinophil Awareness Week ...
Find out More2022-04-13 12:00:20
(Atlanta, GA) --The Board of Directors of the American Partnership for Eosinophilic Disorders (APFED) has announced the election of a new board officer, James D ...
Find out More